Effect of Preoperative Weight Loss and Baseline Comorbidity on Short-Term Complications and Reoperations After Laparoscopic Roux-en-Y Gastric Bypass in 2,067 Patients
- PMID: 33768433
- DOI: 10.1007/s11695-021-05331-y
Effect of Preoperative Weight Loss and Baseline Comorbidity on Short-Term Complications and Reoperations After Laparoscopic Roux-en-Y Gastric Bypass in 2,067 Patients
Abstract
Purpose: Decreasing popularity of Roux-en-Y gastric bypass (RYGB) in bariatric-metabolic surgery may be due to higher perceived peri-operative complications. There are few studies on whether preoperative weight loss can reduce complications or reoperations following RYGB. We investigated this using a standardised operative technique.
Materials and methods: Retrospective single-centre study of RYGB from 2004 to 2019 using a prospective database. Preoperative behavioural management included intentional weight loss. Maximum preoperative weight, weight on the day of operation, and Obesity-Surgery Mortality Risk Score (OS-MRS) class were recorded. Short-term outcomes (post-operative stay, 30-day complication and reoperation rates) were analysed.
Results: In 2,067 RYGB patients (1,901 primary and 166 revisional), median preoperative total body weight loss (TWL) was 6.2% (IQR: 2.5-10.7%). The median age was 46 (interquartile range (IQR) 38-54) and 80.4% were female (n=1,661). For primary surgery, the median body mass index (BMI) was 47.6 kg/m2 (IQR: 43.1-53.3). Excluding the 100-procedure learning curve, the complication rate for primary cases was 4.4% and reoperation rate of 2.8% and one peri-operative mortality (0.06%). OS-MRS ≥2 (class B or C) predicted higher risk of complications (6.1%) compared to those with a score <2 (class A) (3.8%, p=0.021), but not reoperations. Five percent preoperative TWL did not decrease complications compared to <5% TWL. Patients with ≥10% TWL had greater baseline risk and had an increased risk of complications (6.6% vs 3.7%, p=0.017) and reoperations (4.5% vs 2.7%, p<0.001).
Conclusions: RYGB performed using a standardised technique has low overall risk. The influence of preoperative weight loss on outcomes was inconsistent.
Keywords: Obesity Surgery-Mortality Risk Score; Obesity surgery; Roux en Y gastric bypass; bariatric surgery; perioperative complications; short-term outcomes.
Similar articles
-
Gastric band conversion to Roux-en-Y gastric bypass shows greater weight loss than conversion to sleeve gastrectomy: 5-year outcomes.Surg Obes Relat Dis. 2018 Oct;14(10):1531-1536. doi: 10.1016/j.soard.2018.06.002. Epub 2018 Jun 10. Surg Obes Relat Dis. 2018. PMID: 30449510
-
One anastomosis gastric bypass vs. Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgery.Obes Surg. 2020 Sep;30(9):3287-3294. doi: 10.1007/s11695-020-04536-x. Obes Surg. 2020. PMID: 32307669 Free PMC article.
-
How Sustained is Roux-en-Y Gastric Bypass Long-term Efficacy? : Roux-en-Y Gastric Bypass efficacy.Obes Surg. 2021 Aug;31(8):3623-3629. doi: 10.1007/s11695-021-05458-y. Epub 2021 May 22. Obes Surg. 2021. PMID: 34021884 Free PMC article.
-
Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.Int J Surg. 2020 Apr;76:101-110. doi: 10.1016/j.ijsu.2020.02.035. Epub 2020 Mar 6. Int J Surg. 2020. PMID: 32151750
-
Robotic and laparoscopic Roux-en-Y gastric bypass after learning curve: 30-day and 12-month outcomes.J Robot Surg. 2022 Dec;16(6):1257-1263. doi: 10.1007/s11701-022-01384-y. Epub 2022 Feb 26. J Robot Surg. 2022. PMID: 35218480 Review.
Cited by
-
Clinical Outcomes of Resectional Roux-en-Y Gastric Bypass, Compared to Sleeve Gastrectomy for Severe Obesity.Obes Surg. 2023 May;33(5):1338-1346. doi: 10.1007/s11695-023-06544-z. Epub 2023 Mar 20. Obes Surg. 2023. PMID: 36940018
-
BAROS PROTOCOL IN A UNIVERSITY HOSPITAL: WHAT IS THE IMPORTANCE IN THE POSTOPERATIVE RESULTS OF BARIATRIC SURGERY?Arq Bras Cir Dig. 2023 Mar 20;36:e1726. doi: 10.1590/0102-672020230002e1726. eCollection 2023. Arq Bras Cir Dig. 2023. PMID: 36946849 Free PMC article.
-
Medication following bariatric surgery for type 2 diabetes mellitus (BY-PLUS) study: rationale and design of a randomised controlled study.BMJ Open. 2022 Jul 25;12(7):e054313. doi: 10.1136/bmjopen-2021-054313. BMJ Open. 2022. PMID: 35879015 Free PMC article. Clinical Trial.
-
Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery.Biomedicines. 2023 Oct 13;11(10):2785. doi: 10.3390/biomedicines11102785. Biomedicines. 2023. PMID: 37893158 Free PMC article.
-
Roux en Y gastric bypass and iterative intussusception at the jejuno-jejunal anastomosis: Conversion into one anastomosis gastric bypass (with video) - A case report.Int J Surg Case Rep. 2024 Feb;115:109244. doi: 10.1016/j.ijscr.2024.109244. Epub 2024 Jan 10. Int J Surg Case Rep. 2024. PMID: 38215577 Free PMC article.
References
-
- Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in swedish obese subjects. N Engl J Med. 2007;357(8):741–52. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials